Third Harmonic Bio (THRD) Stock Price, News & Analysis

Company Overview

TF Financial Corporation is a savings and loan holding company. The Company's direct and indirect subsidiaries include Third Federal Bank (the Bank), Teragon Financial Corporation, Penns Trail Development Corporation and Third Delaware Corporation. The Bank is a community oriented Pennsylvania stock savings bank offering a variety of financial services to meet the needs of the communities it serves. As of December 31, 2011 the Bank operated fourteen branch offices in Bucks and Philadelphia Counties, Pennsylvania and in Mercer County, New Jersey. During the year ended December 31, 2011, the Company's subsidiary, TF Investments Corporation merged into TF Financial Corporation. In July 2013, the Company acquired Roebling Financial Corp, Inc. (Roebling) and its wholly-owned subsidiary, Roebling Bank.

Key Stats

• Today's Range: $5.38 to $5.38
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 247,013 shs
• Market Capitalization: $242.80 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

THRD Stock Analysis - Frequently Asked Questions

How were Third Harmonic Bio's earnings last quarter?

Third Harmonic Bio, Inc. (NASDAQ:THRD) posted its earnings results on Thursday, May, 8th. The company reported ($0.35) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by $0.09.

When did Third Harmonic Bio IPO?

Third Harmonic Bio (THRD) raised $185 million in an initial public offering (IPO) on Wednesday, September 14th 2022. The company issued 10,900,000 shares at a price of $16.00-$18.00 per share.

What other stocks do shareholders of Third Harmonic Bio own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Third Harmonic Bio investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), ServiceNow (NOW) and e.l.f. Beauty (ELF).

Company Calendar

• Last Earnings: 5/08/2025
• Today: 5/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: N/A
• Current Symbol: NASDAQ:THRD
• CIK: 921051
• Web: www.thirdfedbank.com
• Phone: +1-215-5794000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.62)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$45.47 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -19.27%
• Return on Assets: -18.67%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 54.10
• Quick Ratio: 54.10

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $6.33 per share
• Price / Book: 0.85

Miscellaneous

• Outstanding Shares: 45,130,000
• Free Float: 41,608,000
• Market Cap: $242.80 million
• Optionable: No Data
• Beta: 2.12